Alan F. Schatzberg, MD

Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California

  • 42Articles
  • 93.4KReads
  • 1997–2025Active
  • 89Collaborators
  • 69Citations

About

Alan F. Schatzberg, MD, has contributed to Psychiatrist.com from 1997 to 2025, authoring 42 articles. His work focuses on topics including depression, anxiety, anxiolytics, bipolar disorder, somatoform disorders, violence and aggression, cognition, and neurology. He has frequently collaborated with Martin B. Keller, Michael E. Thase, Madhukar H. Trivedi, A. John Rush, and Daniel N. Klein.

Publications

JCP
In Memoriam: Terence A. Ketter, MD
In Memoriam

In Memoriam: Terence A. Ketter, MD

August 18, 2025

Eminent bipolar disorder researcher and clinician Terence A. Ketter, MD, is remembered.
,
JCP
Baseline Cognition Is Not Associated With Depression Outcomes in Vortioxetine
Original Research

Baseline Cognition Is Not Associated With Depression Outcomes in Vortioxetine

September 4, 2024

This study suggests that cognitive function does not moderate depression outcomes in vortioxetine, with results comparable to other antidepressants.
, , , et al
JCP
Original Research

Antidepressant Side Effects and Panic

April 26, 2017

Do depressed patients with comorbid panic disorder have antidepressant treatment side effect profiles that differ from those of patients without panic disorder? Check out this article to review the...
, , , et al
JCP
Academic Highlights

Overview of Vortioxetine (Brintellix)

December 24, 2014

Understand what is Vortioxetine (Brintellix), an antidepressant for major depressive disorder and treatment-resistant depression.
, , , et al
JCP
Original Research

The Prevention of Recurrent Episodes of Depression With Venlafaxine for Two Years (PREVENT) Study: Outcomes From the 2-Year and Combined Maintenance Phases

August 15, 2007

, , , et al
JCP
Article

Safety and Tolerability of Antidepressants: Weighing the Impact on Treatment Decisions

July 16, 2007

JCP
Original Research

Prevention of Recurrent Episodes of Depression With Venlafaxine ER in a 1-Year Maintenance Phase From the PREVENT Study

July 16, 2007

, , , et al
JCP
Original Research

Addition of Atomoxetine for Depression Incompletely Responsive to Sertraline: A Randomized, Double-Blind, Placebo-Controlled Study

April 16, 2007

, , , et al
JCP
Academic Highlights

Transcranial Magnetic Stimulation: Potential New Treatment for Resistant Depression.

February 15, 2007

, , , et al
JCP
Article

Antidepressant Discontinuation Syndrome: Consensus Panel Recommendations for Clinical Management and Additional Research.

April 15, 2006

, , , et al
JCP
Article

Employing Pharmacologic Treatment of Bipolar Disorder to Greatest Effect

November 15, 2004

PCC
Article

Recognizing and Treating the Physical Symptoms of Depression in Primary Care

August 13, 2004

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe